Dr. Richardson's latest tweets:

    Buy Atomoxetine (Strattera) capsules online

    Atomoxetine (trade names include Strattera, Abretia, Attentin, Attentrol, Axepta) is a selective norepinephrine reuptake inhibitor (SNRI) from centrally acting sympathomimetics pharmacological group. This medication is used to treat attention deficit hyperactivity disorder (ADHD) in children 6 years or older and adults; for the treatment of people with major depression, fibromyalgia, social anxiety disorder. Atomoxetine increases certain endogeneous chemicals (eg, norepinephrine) in the brain, thats why it is not a stimulant like other drugs for ADHD. The advantage of Atomoxetine HCL over stimulants for the treatment of ADHD is that it has less abuse potential than stimulants, is not scheduled as a controlled substance and has proven in clinical trials to offer 24 hour coverage of symptoms associated with ADHD in children and adults. Strattera can improve attention span, concentration, and emotional control. This medicine also reduces restless or overactive behavior.

    How and where to order Atomoxetine (Strattera) capsules or tablets online:


    Prices: from $0.51 per pill

    Forms: Strattera (Atomoxetine) 10, 18, 25, 40 mg tablets or capsules

    Quantity: 30-360 pills

    Type: Strattera (Atomoxetine HCl) generic

    Payment: Visa, MasterCard

    Delivery: AirMail, EMS

    Shipping: Worldwide, including USA, UK, Europe, Canada, Australia

    Related medications:

  • Amfetamine (Amphetamine)
  • Aripiprazole (Abilify)
  • Buspirone (Buspar)
  • Chlorpromazine (Thorazine)
  • Clomipramine (Anafranil)
  • Clozapine (Clozaril)
  • Dexamfetamine (Dexamphetamine)
  • Dexmethylphenidate (Focalin)
  • Divalproex (Depakote)
  • Fencamfamin (Fencamfamine)
  • Fenetylline (Fenethylline)
  • Fenozolone (Ordinator)
  • Lamotrigine (Lamictal)
  • Lisdexamfetamine (Vyvanse)
  • Lithium Carbonate (Lithobid)
  • Loxapine (Loxitane)
  • Metamfetamine (Metamphetamine)
  • Methylphenidate (Concerta)
  • Modafinil (Provigil)
  • Olanzapine (Zyprexa)
  • Paroxetine (Paxil)
  • Pemoline (Cylert)
  • Piracetam (Nootropil)
  • Prochlorperazine (Compazine)
  • Quetiapine (Seroquel)
  • Risperidone (Risperdal)
  • Thioridazine (Mellaril)
  • Ziprasidone (Geodon)

    Pharmacological and medical categories:

  • Antidepressants
  • CNS drugs and agents for ADHD
  • CNS stimulants
  • Central nervous system agents
  • Selective norepinephrine (noradrenaline) reuptake inhibitors (SNRI)
  • Stimulant drugs

    ATC codes:

  • N - Nervous system
  • N06 - Psychoanaleptics
  • N06B - Psychostimulants, agents used for adhd and nootropics
  • N06BA - Centrally acting sympathomimetics
  • N06BA09 - Atomoxetine

    ICD-10 codes:

  • Major depressive disorder, single episode - F32
  • Major depressive disorder, recurrent - F33
  • Phobic anxiety disorders - F40
  • Attention-deficit hyperactivity disorders (Hyperkinetic disorders) - F90
  • Fibromyalgia - M79.7

    Pregnancy categories:

  • B3 - Australia
  • C - United States (Risk cannot be ruled out)

    Salts and other forms:

  • Atomoxetine Base
  • Atomoxetine Hydrochloride

    Synonyms, international and chemical names:

  • (-)-N-Metyl-3-phenyl-3-(o-tolyloxy)propylamine
  • (-)-Tomoxetine
  • (R)-N-Metyl-3-phenyl-3-(o-tolyloxy)propylamine
  • Atomoksetiini
  • Atomoksetin
  • Atomoksetinas
  • Atomoksetyna
  • Atomoxetin
  • Atomoxetina
  • Atomoxetina Clorhidrato
  • Atomoxetine Chlorhydrate
  • Atomoxetine HCL
  • Atomoxetini Hydrochloridum
  • Atomoxetinum
  • Benzenepropanamine, N-Methyl-Gamma-(2-Methylphenoxy)-, (GammaR)-
  • Tomoxetina
  • Tomoxetine
  • Tomoxetinum

    Brands, generics, trade names:

  • Abretia - Roemmers Laboratorios, Pharma Investi de Chile
  • Apo-Atomoxetine - Apotex
  • Atomox Apex - Multi-Apex Pharma
  • Atomoxetin - Actavis, Sandoz
  • Atomoxetina - Teva, Zentiva
  • Atomoxetine - Dr. Reddy's Laboratories, Mylan, Sandoz, Teva
  • Attentin - Ranbaxy, Solus Pharmaceuticals
  • Attentrol - Sun Pharmaceutical Industries
  • Axepta - Intas Pharmaceuticals
  • Hypercon - Consern Pharma
  • Novo-Atomoxetine - Novopharm
  • Strattera - Eli Lilly

    Indications and usage:

    Strattera (Atomoxetine Hydrochloride) is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).

    Dosage and administration:

    Initial, Target and Maximum Daily Dose for acute and maintenance/extended treatment:

    Body Weight Initial Daily Dose Target Total Daily Dose Maximum Total Daily Dose
    Children and adolescents up to 70 kg 0.5 mg/kg 1.2 mg/kg 1.4 mg/kg
    Children and adolescents over 70kg and adults 40 mg 80 mg 100 mg
    Dosing adjustment - Hepatic Impairment, Strong CYP2D6 Inhibitor, and in patients known to be CYP2D6 poor metabolizers (PMs).

    Dosage forms and strengths:

    Each Strattera capsule contains Atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80, or 100 mg of Atomoxetine.


  • Hypersensitivity to atomoxetine or other constituents of product.
  • Strattera use within 2 weeks after discontinuing MAOI or other drugs that affect brain monoamine concentrations.
  • Narrow angle glaucoma.
  • Pheochromocytoma or history of pheochromocytoma.
  • Severe cardiovascular disorders that might deteriorate with clinically important increases in HR and BP.

    Warnings and precautions:

  • Suicidal Ideation - Monitor for suicidality, clinical worsening, and unusual changes in behavior.
  • Severe Liver Injury - Should be discontinued and not restarted in patients with jaundice or laboratory evidence of liver injury.
  • Serious Cardiovascular Events - Sudden death, stroke and myocardial infarction have been reported in association with atomoxetine treatment. Patients should have a careful history and physical exam to assess for presence of cardiovascular disease. Strattera generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to its noradrenergic effects. Consideration should be given to not using Strattera in adults with clinically significant cardiac abnormalities.
  • Emergent Cardiovascular Symptoms - Patients should undergo prompt cardiac evaluation.
  • Effects on Blood Pressure and Heart Rate - Increase in blood pressure and heart rate; orthostasis and syncope may occur. Use with caution in patients with hypertension, tachycardia, or cardiovascular or cerebrovascular disease.
  • Emergent Psychotic or Manic Symptoms - Consider discontinuing treatment if such new symptoms occur.
  • Bipolar Disorder - Screen patients to avoid possible induction of a mixed/manic episode.
  • Aggressive behavior or hostility shouldbe monitored.
  • Possible allergic reactions, including anaphylactic reactions, angioneurotic edema, urticaria, and rash.
  • Effects on Urine Outflow - Urinary hesitancy and retention may occur.
  • Priapism - Prompt medical attention is required in the event of suspected priapism.
  • Growth - Height and weight should be monitored in pediatric patients.
  • Concomitant Use of Potent CYP2D6 Inhibitors or Use in patients known to be CYP2D6 PMs - Dose adjustment of Strattera may be necessary.

    Adverse reactions, side effects:

    Most common adverse reactions of Strattera (Atomoxetine HCl) capsules ( >= 5% and at least twice the incidence of placebo patients):

  • Child and adolescent clinical trials - nausea, vomiting, fatigue, decreased appetite, abdominal pain, and somnolence.
  • Adult clinical trials - constipation, dry mouth, nausea, decreased appetite, dizziness, erectile dysfunction, and urinary hesitation.

    To report suspected adverse reactions, contact Eli Lilly and Company or U.S. FDA

    Drug interactions:

  • Monoamine Oxidase Inhibitors.
  • CYP2D6 Inhibitors - concomitant use may increase atomoxetine steady-state plasma concentrations in EMs.
  • Antihypertensive drugs and pressor agents - possible effects on blood pressure.
  • Albuterol (or other beta-2 agonists) - action of albuterol (salbutamol) on cardiovascular system can bepotentiated.

    Updated: February 2020
    Reviewed: February 2020